Genetic Technologies Ltd (NASDAQ:GENE)

1.06
Delayed Data
As of Jun 22
 -0.02 / -1.85%
Today’s Change
0.70
Today|||52-Week Range
2.05
-8.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash2.7M14.1M8.3M8.4M
 
 
 
 
 
Short Term Investment Cash1.0M12.9M-5.2M-144.4K
 
 
 
 
 
Cash & Short Term Investments2.7M14.1M8.3M8.4M
 
 
 
 
 
 
ReceivablesReceivables1.0M549.5K469.7K327.0K
 
 
 
 
 
 
InventoriesInventories201.0K244.0K124.3K58.9K
 
 
 
 
 
 
Current AssetsPrepaid Expenses190.6K145.0K111.3K105.0K
 
 
 
 
 
Current Assets4.1M15.0M9.0M8.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross5.5M2.0M2.3M2.5M
 
 
 
 
 
Depreciation-5.1M-1.7M-1.9M-2.2M
 
 
 
 
 
Intangible Assets1.1M565.7K453.1K0.00
 
 
 
 
Other Assets1.1M565.7K453.1K0.00
 
 
 
 
Total Assets6.4M15.9M9.9M9.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable849.7K397.4K292.1K305.5K
 
 
 
 
 
Short Term Debt0.0019.2K0.000.00
 
 
Accrued Expenses223.8K331.0K130.4K233.4K
 
 
 
 
 
Other Current Liabilities662.7K509.7K371.6K447.8K
 
 
 
 
 
Other Liabilities2.2M1.3M991.9K1.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt2.4M0.000.000.00
 
 
Total Liabilities4.6M1.4M1.0M1.2M
 
 
 
 
 
 
EquityMinority Interest-8.5K0.000.000.00
 
 
Preferred Stock0.000.000.000.00--
Common Equity1.7M14.6M8.8M8.1M
 
 
 
 
 
Total Shareholder Equity1.7M14.6M8.8M8.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding4.1M11.4M11.4M16.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.